| Ferric carboxymaltose Teva 50 mg iron/ml dispersion for injection/infusion PA1986/124/001 |
Ferric carboxymaltose |
Teva B.V. |
Marketed |
| Flecainide 100mg Tablets PA1986/050/002 |
Flecainide acetate |
Teva B.V. |
Marketed |
| Flecainide 50mg Tablets PA1986/050/001 |
Flecainide acetate |
Teva B.V. |
Marketed |
| Floxapen 1000 mg powder for solution for injection or infusion PA1986/111/003 |
Flucloxacillin |
Teva B.V. |
Marketed |
| Floxapen 2000 mg powder for solution for injection or infusion PA1986/111/004 |
Flucloxacillin |
Teva B.V. |
Marketed |
| Floxapen 250mg Powder for solution for Injection or Infusion PA1986/111/001 |
Flucloxacillin |
Teva B.V. |
Marketed |
| Floxapen 500 mg Powder for Solution for Injection or Infusion PA1986/111/002 |
Flucloxacillin |
Teva B.V. |
Marketed |
| Fluticasone Furoate Teva 27.5 micrograms/spray, nasal spray, suspension PA1986/126/001 |
Fluticasone furoate |
Teva B.V. |
Marketed |
| Fulvestrant Teva 250 mg Solution for Injection in Pre-filled Syringe PA1986/011/001 |
Fulvestrant |
Teva B.V. |
Marketed |
| Gemcitabine Teva 40 mg/ml Concentrate for Solution for Infusion PA1986/122/001 |
Gemcitabine |
Teva B.V. |
Marketed |
| Hydrocortone 10 mg Tablets PA1986/054/001 |
Hydrocortisone |
Teva B.V. |
Marketed |
| Imatinib Teva 100 mg film-coated tablets EU/1/12/808/001-012 |
Imatinib mesilate |
Teva B.V. |
— |
| Ipramol Steri-Neb 0.5 mg/2.5 mg per 2.5 ml nebuliser solution PA1986/082/001 |
Ipratropium bromide, SALBUTAMOL SULFATE |
Teva B.V. |
Marketed |
| Ipratropium Steri-Neb 250 micrograms/ml Nebuliser solution PA1986/083/001 |
Ipratropium bromide |
Teva B.V. |
Marketed |
| Irinotecan Hydrochloride 20 mg/mL concentrate for solution for infusion PA1986/068/001 |
Irinotecan hydrochloride trihydrate |
Teva B.V. |
Marketed |
| Kentera EU/1/03/270/004-005 |
Oxybutynin hydrochloride |
Teva B.V. |
— |
| Kentera 3.9 mg/24 hours transdermal patch EU/1/03/270/1-2 |
Oxybutynin |
Teva B.V. |
— |
| Lansoprazole Teva Pharma 15 mg gastro-resistant capsules, hard PA1986/008/001 |
Lansoprazole |
Teva B.V. |
Marketed |
| Lansoprazole Teva Pharma 30 mg gastro-resistant capsules, hard PA1986/008/002 |
Lansoprazole |
Teva B.V. |
Marketed |
| Lenalidomide Teva 10 mg hard capsules PA1986/051/004 |
Lenalidomide |
Teva B.V. |
Marketed |
| Lenalidomide Teva 15 mg hard capsules PA1986/051/005 |
Lenalidomide |
Teva B.V. |
Marketed |
| Lenalidomide Teva 2.5 mg hard capsules PA1986/051/001 |
Lenalidomide hydrochloride hydrate |
Teva B.V. |
Not marketed |
| Lenalidomide Teva 20 mg hard capsules PA1986/051/006 |
Lenalidomide |
Teva B.V. |
Marketed |
| Lenalidomide Teva 25 mg hard capsules PA1986/051/007 |
Lenalidomide |
Teva B.V. |
Marketed |
| Lenalidomide Teva 5 mg hard capsules PA1986/051/002 |
Lenalidomide |
Teva B.V. |
Marketed |
| Lenalidomide Teva 7.5 mg hard capsules PA1986/051/003 |
Lenalidomide |
Teva B.V. |
Not marketed |
| Linagliptin Teva 5 mg film-coated tablets PA1986/131/001 |
Linagliptin |
Teva B.V. |
Not marketed |
| Lonquex 6 mg solution for injection in pre-filled syringe EU/1/13/856/001-002 |
Xm22 drug substance lipegfilgrastim |
Teva B.V. |
— |
| Lonquex 6 mg/0.6 ml solution for injection EU/1/13/856/005 |
lipegfilgrastim |
Teva B.V. |
— |
| Lonquex 6 mg/0.6 ml solution for injection EU/1/13/856/004 |
lipegfilgrastim |
Teva B.V. |
— |
| Lycimor 300 mg Capsules, Hard PA1986/118/001 |
Lymecycline |
Teva B.V. |
Marketed |
| Motusol Max 2 % w/w gel PA1986/093/002 |
Diclofenac Diethylamine |
Teva B.V. |
Marketed |
| Motusol Rx 1 % w/w gel PA1986/093/001 |
Diclofenac Diethylamine |
Teva B.V. |
Not marketed |
| Mycophenolate mofetil Teva 250 mg Capsule, hard EU/1/07/439/1-2 |
Mycophenolate mofetil |
Teva B.V. |
— |
| Myfenax 250 mg Capsule, hard EU/1/07/438/1-2 |
Mycophenolate mofetil |
Teva B.V. |
— |
| Myfenax 500 mg Film-coated tablet EU/1/07/438/3-4 |
Mycophenolate mofetil |
Teva B.V. |
— |
| Nasobec 50 Micrograms Aqueous Nasal Spray PA1986/055/001 |
Beclometasone dipropionate |
Teva B.V. |
Marketed |
| Nasofan Aqueous 50 microgram Nasal Spray Suspension PA1986/084/001 |
Fluticasone propionate |
Teva B.V. |
Marketed |
| Nasusaf 137 micrograms/50 micrograms per actuation nasal spray, suspension PA1986/109/001 |
Azelastine hydrochloride, Fluticasone propionate |
Teva B.V. |
Marketed |
| Neotigason 10 mg capsules PA1986/113/001 |
Acitretin |
Teva B.V. |
Marketed |
| Neotigason 25 mg capsules PA1986/113/002 |
Acitretin |
Teva B.V. |
Marketed |
| Neurostil 100 mg hard capsules PA1986/128/001 |
Gabapentin |
Teva B.V. |
Not marketed |
| Neurostil 300 mg hard capsules PA1986/128/002 |
Gabapentin |
Teva B.V. |
Not marketed |
| Neurostil 400 mg hard capsules PA1986/128/003 |
Gabapentin |
Teva B.V. |
Not marketed |
| Nortem 10mg Tablets PA1986/085/001 |
Temazepam |
Teva B.V. |
Marketed |
| Nortem 20mg Tablets PA1986/085/002 |
Temazepam |
Teva B.V. |
Marketed |
| Olatuton 10 mg powder and solvent for prolonged-release suspension for injection PA1986/076/001 |
Octreotide |
Teva B.V. |
Not marketed |
| Olatuton 20 mg powder and solvent for prolonged-release suspension for injection PA1986/076/002 |
Octreotide |
Teva B.V. |
Not marketed |
| Olatuton 30 mg powder and solvent for prolonged-release suspension for injection PA1986/076/003 |
Octreotide |
Teva B.V. |
Not marketed |
| Paracetamol Teva 500 mg film-coated tablets PA1986/101/001 |
Paracetamol |
Teva B.V. |
Not marketed |